273 related articles for article (PubMed ID: 23669331)
1. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
[TBL] [Abstract][Full Text] [Related]
2. Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses.
Amberg A; Beilke L; Bercu J; Bower D; Brigo A; Cross KP; Custer L; Dobo K; Dowdy E; Ford KA; Glowienke S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Nicolette J; Plaper A; Powley M; Quigley DP; Reddy MV; Spirkl HP; Stavitskaya L; Teasdale A; Weiner S; Welch DS; White A; Wichard J; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():13-24. PubMed ID: 26877192
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure.
Araya S; Lovsin-Barle E; Glowienke S
Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093
[TBL] [Abstract][Full Text] [Related]
4. The Consultancy Activity on In Silico Models for Genotoxic Prediction of Pharmaceutical Impurities.
Pavan M; Kovarich S; Bassan A; Broccardo L; Yang C; Fioravanzo E
Methods Mol Biol; 2016; 1425():511-29. PubMed ID: 27311479
[TBL] [Abstract][Full Text] [Related]
5. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.
Powley MW
Regul Toxicol Pharmacol; 2015 Mar; 71(2):295-300. PubMed ID: 25545315
[TBL] [Abstract][Full Text] [Related]
6. Validation of Toxtree and SciQSAR in silico predictive software using a publicly available benchmark mutagenicity database and their applicability for the qualification of impurities in pharmaceuticals.
Contrera JF
Regul Toxicol Pharmacol; 2013 Nov; 67(2):285-93. PubMed ID: 23969001
[TBL] [Abstract][Full Text] [Related]
7. In silico prediction of genotoxicity.
Wichard JD
Food Chem Toxicol; 2017 Aug; 106(Pt B):595-599. PubMed ID: 27979779
[TBL] [Abstract][Full Text] [Related]
8. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.
Dobo KL; Greene N; Fred C; Glowienke S; Harvey JS; Hasselgren C; Jolly R; Kenyon MO; Munzner JB; Muster W; Neft R; Reddy MV; White AT; Weiner S
Regul Toxicol Pharmacol; 2012 Apr; 62(3):449-55. PubMed ID: 22321701
[TBL] [Abstract][Full Text] [Related]
9. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
[TBL] [Abstract][Full Text] [Related]
10. Use of In Silico Methods for Regulatory Toxicological Assessment of Pharmaceutical Impurities.
Kovarich S; Cappelli CI
Methods Mol Biol; 2022; 2425():537-560. PubMed ID: 35188646
[TBL] [Abstract][Full Text] [Related]
11. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
[TBL] [Abstract][Full Text] [Related]
12. Carbamates and ICH M7 classification: Making use of expert knowledge.
Hemingway R; Fowkes A; Williams RV
Regul Toxicol Pharmacol; 2017 Jun; 86():392-401. PubMed ID: 28385577
[TBL] [Abstract][Full Text] [Related]
13. Assessing the impact of expert knowledge on ICH M7 (Q)SAR predictions. Is expert review still needed?
Jayasekara PS; Skanchy SK; Kim MT; Kumaran G; Mugabe BE; Woodard LE; Yang J; Zych AJ; Kruhlak NL
Regul Toxicol Pharmacol; 2021 Oct; 125():105006. PubMed ID: 34273441
[TBL] [Abstract][Full Text] [Related]
14. A novel QSAR model of Salmonella mutagenicity and its application in the safety assessment of drug impurities.
Valencia A; Prous J; Mora O; Sadrieh N; Valerio LG
Toxicol Appl Pharmacol; 2013 Dec; 273(3):427-34. PubMed ID: 24090816
[TBL] [Abstract][Full Text] [Related]
15. Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities.
Fioravanzo E; Bassan A; Pavan M; Mostrag-Szlichtyng A; Worth AP
SAR QSAR Environ Res; 2012; 23(3-4):257-77. PubMed ID: 22369620
[TBL] [Abstract][Full Text] [Related]
16. Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses.
Amberg A; Andaya RV; Anger LT; Barber C; Beilke L; Bercu J; Bower D; Brigo A; Cammerer Z; Cross KP; Custer L; Dobo K; Gerets H; Gervais V; Glowienke S; Gomez S; Van Gompel J; Harvey J; Hasselgren C; Honma M; Johnson C; Jolly R; Kemper R; Kenyon M; Kruhlak N; Leavitt P; Miller S; Muster W; Naven R; Nicolette J; Parenty A; Powley M; Quigley DP; Reddy MV; Sasaki JC; Stavitskaya L; Teasdale A; Trejo-Martin A; Weiner S; Welch DS; White A; Wichard J; Woolley D; Myatt GJ
Regul Toxicol Pharmacol; 2019 Mar; 102():53-64. PubMed ID: 30562600
[TBL] [Abstract][Full Text] [Related]
17. Prediction of genotoxic potential of cosmetic ingredients by an in silico battery system consisting of a combination of an expert rule-based system and a statistics-based system.
Aiba née Kaneko M; Hirota M; Kouzuki H; Mori M
J Toxicol Sci; 2015 Feb; 40(1):77-98. PubMed ID: 25743748
[TBL] [Abstract][Full Text] [Related]
18. A practical application of two in silico systems for identification of potentially mutagenic impurities.
Greene N; Dobo KL; Kenyon MO; Cheung J; Munzner J; Sobol Z; Sluggett G; Zelesky T; Sutter A; Wichard J
Regul Toxicol Pharmacol; 2015 Jul; 72(2):335-49. PubMed ID: 25980641
[TBL] [Abstract][Full Text] [Related]
19. A practice of expert review by read-across using QSAR Toolbox.
Fukuchi J; Kitazawa A; Hirabayashi K; Honma M
Mutagenesis; 2019 Mar; 34(1):49-54. PubMed ID: 30690463
[TBL] [Abstract][Full Text] [Related]
20. A consortium-driven framework to guide the implementation of ICH M7 Option 4 control strategies.
Barber C; Antonucci V; Baumann JC; Brown R; Covey-Crump E; Elder D; Elliott E; Fennell JW; Gallou F; Ide ND; Jordine G; Kallemeyn JM; Lauwers D; Looker AR; Lovelle LE; McLaughlin M; Molzahn R; Ott M; Schils D; Oestrich RS; Stevenson N; Talavera P; Teasdale A; Urquhart MW; Varie DL; Welch D
Regul Toxicol Pharmacol; 2017 Nov; 90():22-28. PubMed ID: 28822875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
